ADC Therapeutics (ADCT) Revenue (2021 - 2026)
ADC Therapeutics (ADCT) posted quarterly Revenue of $20.9 million for Q1 2026, down 9.47% year-on-year from $23.0 million in Q1 2025, and up 26.93% on a QoQ basis from $16.4 million in Q3 2025.
ADC Therapeutics (ADCT) Revenue (2021 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Revenue for 6 consecutive years, with $20.9 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | 20.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.85 Mn |
| Sep 30, 2025 | 16.43 Mn |
| Jun 30, 2025 | 18.84 Mn |
| Mar 31, 2025 | 23.03 Mn |
| Sep 30, 2024 | 18.46 Mn |
| Jun 30, 2024 | 17.41 Mn |
| Mar 31, 2024 | 18.05 Mn |
| Sep 30, 2023 | 14.49 Mn |
| Jun 30, 2023 | 19.28 Mn |
| Mar 31, 2023 | 18.99 Mn |
| Sep 30, 2022 | 76.32 Mn |
| Jun 30, 2022 | 17.29 Mn |
| Mar 31, 2022 | 46.50 Mn |
| Sep 30, 2021 | 13.15 Mn |
| Jun 30, 2021 | 3.76 Mn |